chr11-1411461-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1
The NM_001256627.2(BRSK2):c.91+21086T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.464 in 1,470,786 control chromosomes in the GnomAD database, including 166,451 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.43 ( 14851 hom., cov: 34)
Exomes 𝑓: 0.47 ( 151600 hom. )
Consequence
BRSK2
NM_001256627.2 intron
NM_001256627.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0120
Genes affected
BRSK2 (HGNC:11405): (BR serine/threonine kinase 2) Enables several functions, including ATP binding activity; ATPase binding activity; and protein kinase activity. Involved in several processes, including cellular protein metabolic process; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; and regulation of insulin secretion involved in cellular response to glucose stimulus. Located in centrosome and endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.05).
BP6
Variant 11-1411461-T-C is Benign according to our data. Variant chr11-1411461-T-C is described in ClinVar as [Benign]. Clinvar id is 3059255.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.491 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BRSK2 | NM_001256627.2 | c.91+21086T>C | intron_variant | ENST00000528841.6 | NP_001243556.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BRSK2 | ENST00000528841.6 | c.91+21086T>C | intron_variant | 1 | NM_001256627.2 | ENSP00000432000 | P1 |
Frequencies
GnomAD3 genomes AF: 0.428 AC: 65119AN: 152078Hom.: 14840 Cov.: 34
GnomAD3 genomes
AF:
AC:
65119
AN:
152078
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.396 AC: 49994AN: 126252Hom.: 11462 AF XY: 0.403 AC XY: 28221AN XY: 70074
GnomAD3 exomes
AF:
AC:
49994
AN:
126252
Hom.:
AF XY:
AC XY:
28221
AN XY:
70074
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.468 AC: 616859AN: 1318590Hom.: 151600 Cov.: 55 AF XY: 0.463 AC XY: 298314AN XY: 644582
GnomAD4 exome
AF:
AC:
616859
AN:
1318590
Hom.:
Cov.:
55
AF XY:
AC XY:
298314
AN XY:
644582
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.428 AC: 65181AN: 152196Hom.: 14851 Cov.: 34 AF XY: 0.423 AC XY: 31503AN XY: 74402
GnomAD4 genome
AF:
AC:
65181
AN:
152196
Hom.:
Cov.:
34
AF XY:
AC XY:
31503
AN XY:
74402
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
511
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
BRSK2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 18, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at